TrialBlood advances2024
Final outcomes from a phase 2 trial of posoleucel in allogeneic hematopoietic cell transplant recipients.
Sanjeet S Dadwal et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
13 papers cite it
this paperpooled ittrialcites it